Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	128K 149K 119K 109K 205K 14.24M 208K 1.41M 550K 7.15M 559K 547K 23.67M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 15.46M 12.39M 11.34M 21.28M 1.48B 21.56M 146M 57.08M 743M 58.04M 56.77M 2.46B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

Jun. 30	Safe Group sharply improves its full-year results
Jun. 28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
May. 28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
May. 28	Safe Group enters Peru with exclusive distribution agreement
Mar. 16	Changes to the SAFE Board of Directors
Dec. 17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
Dec. 17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
Nov. 30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-07-28	Alert wrongly tagged to Safe SA withdrawn	RE
24-12-27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-09-09	The market burns its idols
24-02-05	Safe: wins its appeal against Neo Medical
23-12-28	Safe: audit initiated for a turnaround plan

Dec. 22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
Dec. 17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
Dec. 17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
24-09-09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
23-11-24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

Jun. 30	Safe Group améliore nettement ses résultats annuels
May. 28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
Apr. 28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
Mar. 31	SAFE - Forte dynamique de développement au Venezuela
Mar. 16	Evolutions au sein du Conseil d'Administration de SAFE

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	2010-02-14
François-Henri Reynaud DFI	Director of Finance/CFO	-	2017-11-08

Safe Orthopaedics Stock Euronext Paris

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics

Latest news : Safe Orthopaedics

Press Releases: Safe Orthopaedics

News in other languages: Safe Orthopaedics

Quotes and Performance

Managers and Directors: Safe Orthopaedics

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	2019-11-25
Ismaël Nujurally BRD	Director/Board Member	69	2019-11-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS	-0.79%	-8.36%	-	-	149K
STRYKER CORPORATION	+0.53%	-2.88%	-14.39%	+19.26%	126B
SMITH & NEPHEW PLC	-0.37%	-2.42%	-22.78%	0.00%	12.26B
GLAUKOS CORPORATION	0.00%	+0.20%	+105.91%	+153.52%	10.9B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-4.90%	-8.39%	-51.16%	-69.73%	4.14B
DOUBLE MEDICAL TECHNOLOGY INC.	-0.43%	-1.43%	-24.43%	+49.81%	2.69B
INSPIRE MEDICAL SYSTEMS, INC.	+1.78%	+9.21%	-31.94%	-71.42%	1.8B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-1.13%	-0.43%	-23.87%	-13.53%	1.66B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-3.68%	-3.53%	-36.09%	-38.01%	1.61B
Average	-1.00%	-0.61%	-12.34%	+3.74%	20.18B
Weighted average by Cap.	+0.23%	-2.52%	-8.52%	+23.17%

	2024	2025
Net sales	5.04M 5.88M 4.72M 4.32M 8.1M 563M 8.21M 55.73M 21.73M 283M 22.1M 21.62M 936M	5.36M 6.26M 5.02M 4.59M 8.62M 599M 8.74M 59.3M 23.12M 301M 23.51M 23M 996M
Net income	-1.93B -2.25B -1.81B -1.65B -3.1B -215B -3.14B -21.33B -8.32B -108B -8.46B -8.27B -358B	-4.67M -5.46M -4.37M -4M -7.51M -522M -7.61M -51.67M -20.15M -262M -20.49M -20.04M -867M
Net Debt	11.47M 13.39M 10.73M 9.82M 18.44M 1.28B 18.68M 127M 49.45M 644M 50.28M 49.19M 2.13B	13.11M 15.31M 12.27M 11.23M 21.08M 1.46B 21.35M 145M 56.53M 736M 57.48M 56.23M 2.43B